$HSTC
HST Global Inc

2022 Q2 Form 10-Q Financial Statement

#000167479622000012 Filed on July 26, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $34.53K $38.22K
YoY Change -9.65% -12.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $34.53K $38.22K
YoY Change -9.66% -12.79%
Operating Profit -$34.53K -$38.22K
YoY Change -9.66% -12.79%
Interest Expense $986.00 $662.00
YoY Change 48.94% 221.36%
% of Operating Profit
Other Income/Expense, Net -$986.00 -$662.00
YoY Change 48.94% 221.36%
Pretax Income -$35.51K -$38.88K
YoY Change -8.66% -11.69%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$35.51K -$38.88K
YoY Change -8.66% -11.69%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$6.766K -$7.408K
COMMON SHARES
Basic Shares Outstanding 5.249M shares 5.249M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $370.00 $1.120K
YoY Change -66.96% -23.81%
Cash & Equivalents $365.00 $1.121K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $365.00 $1.121K
YoY Change -67.44% -23.74%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $365.00 $1.121K
Total Long-Term Assets $0.00 $0.00
Total Assets $365.00 $1.121K
YoY Change -67.44% -23.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $302.3K $182.3K
YoY Change 65.83% 194.62%
Accrued Expenses $5.520K $2.110K
YoY Change 161.61% 859.09%
Deferred Revenue
YoY Change
Short-Term Debt $67.08K $46.78K
YoY Change 43.39% 115.77%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $374.9K $231.2K
YoY Change 62.17% 175.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $374.9K $231.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $374.9K $231.2K
YoY Change 62.17% 175.98%
SHAREHOLDERS EQUITY
Retained Earnings -$5.797M -$5.653M
YoY Change 2.56% 3.82%
Common Stock $5.248K $5.249K
YoY Change -0.02% 23.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$374.5K -$230.0K
YoY Change
Total Liabilities & Shareholders Equity $365.00 $1.121K
YoY Change -67.44% -23.74%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income -$35.51K -$38.88K
YoY Change -8.66% -11.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.760K -$14.88K
YoY Change -68.01% 221.38%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.000K 16.00K
YoY Change -68.75% 161.87%
NET CHANGE
Cash From Operating Activities -4.760K -14.88K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 5.000K 16.00K
Net Change In Cash 240.0 1.120K
YoY Change -78.57% -24.32%
FREE CASH FLOW
Cash From Operating Activities -$4.760K -$14.88K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
242275 usd
CY2022Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
67077 usd
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
55077 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5523 usd
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Entity File Number
EntityFileNumber
000-15303
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
3656 usd
dei Entity Registrant Name
EntityRegistrantName
HST Global, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1215433
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Research Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Hampton
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23666
dei City Area Code
CityAreaCode
757
dei Local Phone Number
LocalPhoneNumber
766-6100
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5248582 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
365 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
365 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
225 usd
CY2022Q2 us-gaap Assets
Assets
365 usd
CY2021Q4 us-gaap Assets
Assets
225 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
302275 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
374875 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
301008 usd
CY2022Q2 us-gaap Liabilities
Liabilities
374875 usd
CY2021Q4 us-gaap Liabilities
Liabilities
301008 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
5248 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5248 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5417236 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5417236 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5796994 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5723267 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-374510 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-300783 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
365 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30000 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4527 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8217 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11860 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16521 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
34527 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
38217 usd
us-gaap Operating Expenses
OperatingExpenses
71860 usd
us-gaap Operating Expenses
OperatingExpenses
76521 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34527 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-38217 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-71860 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-76521 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
986 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
662 usd
us-gaap Interest Expense
InterestExpense
1867 usd
us-gaap Interest Expense
InterestExpense
1097 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-986 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-662 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1867 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1097 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35513 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38879 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73727 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77618 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35513 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-38879 usd
us-gaap Net Income Loss
NetIncomeLoss
-73727 usd
us-gaap Net Income Loss
NetIncomeLoss
-77618 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5248582 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5248582 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5248582 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5248582 shares
us-gaap Profit Loss
ProfitLoss
-73727 usd
us-gaap Profit Loss
ProfitLoss
-77618 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4918 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
60000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
60800 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1867 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1097 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11860 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20639 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21100 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
140 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
461 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
660 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
365 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1121 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES </b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">HST Global, Inc. was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">To date we have been unable to initiate our original business plan.  While we are continuing to seek opportunities to do so, we are also seeking other opportunities to integrate assets, rights, or other potential revenue streams.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2021. The results of operations for the period ended June 30, 2022, are not necessarily indicative of the results for a full-year period.</p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and 10-Q.  </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-family:Times New Roman">liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>

Files In Submission

Name View Source Status
hstc-20220630_lab.xml Edgar Link unprocessable
0001674796-22-000012-index-headers.html Edgar Link pending
0001674796-22-000012-index.html Edgar Link pending
0001674796-22-000012.txt Edgar Link pending
0001674796-22-000012-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstc-20220630.htm Edgar Link pending
hstc-20220630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hstc-20220630_cal.xml Edgar Link unprocessable
hstc-20220630_def.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hstc-20220630_pre.xml Edgar Link unprocessable
hstc-20220630_htm.xml Edgar Link completed